---
trial_id: 8
discovery_date: 2022-03-09 19:26:18.166929
date: 2022-03-09 19:26:18.166929
title: "Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf"
summary: |
  <b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Interventions</b>:    Other: Ofatumumab;   Other: Ocrelizumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05266469?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-03-04 17:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Interventions</b>:    Other: Ofatumumab;   Other: Ocrelizumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>